Hepatitis C RNA prevalence before and during broad access to direct-acting antivirals in people with HIV across six countries.

Access publication

Citation: Stewart AC, Yiannoutsos CT, Pavlyshyn D, Wittkop L, Bonnet F, Jarrín I, Berenguer J, Baumann L, Kusejko K, van der Valk M, Smit C, Stoové MA, Asselin J, Doyle JS, Klein M, Lancombe K, Salmon D, Matthews G, Prins M, Bakoyannis G, Musick B, Hellard M, Sacks-Davis R; InCHEHC study group. Hepatitis C RNA prevalence before and during broad access to direct-acting antivirals in people with HIV across six countries. JHEP Rep. 2026 Sep 30:102054. doi: 10.1016/j.jhepr.2026.102054. Epub ahead of print. PMID: 42815635.